Neurotoxicity Good Review Practices Guidance To Be Finalized In 1998
Executive Summary
A good review practices guidance on neurotoxicity will be completed within the next six months, Neuro-pharmacology Research Program Director David Lester, PhD, predicted at a June 23 meeting of FDA's Advisory Committee for Pharmaceutical Science.